Teva Pharmaceutical Industries (TEVA) EBT Growth (3y) (2012 - 2026)
Powered by 
Analysis
Teva Pharmaceutical Industries (TEVA) EBT Growth (3y) (2012 - 2026) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBT Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 42.57 Bn | 38.91 Bn | 2.15 Bn | 21.00% |
| 2 | Viatris | 19.20 Bn | 18.31 Bn | 1.46 Bn | -29.91% |
| 3 | Dr Reddys Laboratories | 9.86 Bn | 9.69 Bn | 396.53 Mn | -36.69% |
| 4 | Amneal Pharmaceuticals | 5.48 Bn | 5.35 Bn | 334.51 Mn | 33.76% |
| 5 | Bausch Health Companies | 2.36 Bn | 520.75 Mn | 2.10 Bn | 63.93% |
| 6 | Alvotech | 1.50 Bn | 1.36 Bn | 2.56 Mn | - |
| 7 | Ani Pharmaceuticals | 1.49 Bn | 1.13 Bn | 165.89 Mn | 91.91% |
| 8 | Amphastar Pharmaceuticals | 995.52 Mn | 705.40 Mn | 93.47 Mn | 5.52% |
| 9 | Fennec Pharmaceuticals | 406.25 Mn | 365.00 Mn | 17.15 Mn | 33.42% |
| 10 | RedHill Biopharma | 176.59 Mn | 176.59 Mn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 21.00% |
| Mar 31, 2026 | 53.36% |
| Dec 31, 2025 | 27.39% |
| Sep 30, 2025 | 55.74% |
| Jun 30, 2025 | 29.51% |
| Mar 31, 2025 | 32.05% |
| Dec 31, 2024 | -12.17% |
| Sep 30, 2024 | -41.75% |
| Jun 30, 2024 | -40.92% |
| Mar 31, 2024 | 48.02% |
| Dec 31, 2023 | 54.68% |
| Sep 30, 2023 | 26.29% |
| Jun 30, 2023 | -162.55% |
| Mar 31, 2023 | -102.00% |
| Dec 31, 2022 | -212.05% |
| Sep 30, 2022 | 37.25% |
| Jun 30, 2022 | -11.49% |
| Mar 31, 2022 | -126.11% |
| Dec 31, 2021 | 62.75% |
| Sep 30, 2021 | 55.96% |